Search Results 651-660 of 19240 for hemoglobin

1. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

   Hemoglobin (Hgb) ≥ 9 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or direct bilirubin ≤ ULN; Serum glutamic oxaloacetic transaminase (SGOT) ...

2. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) ≥ 10.0 g/dl is acceptable); Bilirubin ≤ 1.5 upper ...

3. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

   ... Hemoglobin A1c ≥7%; Part 2c: Patients with uncontrolled diabetes or Hemoglobin A1c >8%. Patients with glucose intolerance or diabetes whose blood glucose ...

4. A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL; Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0, 1 or 2; Provide informed written consent; Women of childbearing ...

5. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   Hemoglobin >7.0 gm/dL, white count >3.0 X 10(9), platelet count >100 X 10(9). Exclusion Criteria: History of HIV; Presence of active infection; New York Hear ...

6. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/deciliter; Serum Creatinine ≤ 1.5 x ULN or creatinine clearance > 40ml/min using the Cockcroft-Gault formula. Female CrCl = (140 - age ...

7. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

   * Hemoglobin \>= 9.0 g/dL (less than or equal to 28 days prior to registration) * Creatinine =\< 2 x upper limit of normal (ULN) (less than or equal to 28 ...

8. Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma - Mayo Clinic

   Hemoglobin ≥ 10.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate (GFR) ≥ 70 mL/min ...

9. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Hemoglobin >= 8.0 g/dL (=< 28 days prior to registration) - Without growth factor support, blood transfusion, or platelet stimulating agents for the past ...

10. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Hemoglobin ≥8.0 g/dL, subjects may receive blood transfusion to achieve hemoglobin eligibility criteria per investigator discretion. Total bilirubin ≤1.5 ...